Nachrichten zur Eli Lilly & Co. Aktie

S&P 500 eases with Eli Lilly; Nasdaq manages record closing high

The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight…

Earnings live: Eli Lilly stock slides, Pinterest sells off, Expedia and Block gain after hours

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive…

Dow, S&P 500 end lower; Eli Lilly shares fall after drug data

The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight…

Eli Lillys Experimental Weight-Loss Pill Data Disappoints

A new, late-stage clinical study shows disappointing results for Eli Lillys weight loss pill Orforglipron. The experimental drug has less…

Eli Lilly Shares Plummet 14% Toward Worst Day In 25 Years—Here’s Why It’s Down

Shares of rival Novo Nordisk rose as both companies develop weight loss pills.…

Stocks making the biggest moves midday: Firefly Aerospace, Fortinet, Duolingo, Eli Lilly and more

Here are some of the stocks posting the biggest moves in midday trading.…

Stocks making the biggest moves midday: Fortinet, Duolingo, Eli Lilly, AppLovin and more

Here are some of the stocks posting the biggest moves in midday trading.…

Drugmakers racing to launch the first weight-loss pill

Weight-loss drugs are expected to pull in more than $150 billion in industry-wide revenue by the early 2030s, thanks to…

Stocks making the biggest moves premarket: Eli Lilly, Peloton, Intel, Duolingo and more

These are the stocks posting the largest moves in premarket trading.…

Eli Lilly shares drop after obesity pill shows modest late-stage trial results

Eli Lillys pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market for…

Market movers: Duolingo, Eli Lilly, Warner Bros, Crocs...

…

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar

Eli Lilly hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight…

Eli Lilly: Neue Abnehmpille zeigt deutliche Wirkung – aber nicht ganz wie erhofft!

Eli Lilly hat neue Studienergebnisse zum oralen GLP?1-Kandidaten Orforglipron vorgelegt. In einer Phase?III-Studie verloren übergewichtige Teilnehmer ohne Diabetes innerhalb von…

Stock Market Today: Dow Futures Rise On Trump Tariff News; Eli Lilly Plunges On Weight-Loss Drug Trial (Live Coverage)

Stock Market Today: The Dow Jones Index rose Thursday on Trump tariff news. Eli Lilly plunged on disappointing weight-loss drug…

Novo Nordisk shares jump as Eli Lillys weight-loss pill data disappoints

Shares in Novo Nordisk rose 13.6% on Thursday after trial data from Eli Lillys experimental weight-loss pill fell short of…

Novo Nordisk shares jump as Eli Lilly obesity pill disappoints By Investing.com

Novo Nordisk shares jump as Eli Lilly obesity pill disappoints…

Lilly raises full-year earnings forecasts on surging demand for weight-loss drug

Eli Lilly raised its full-year profit and sales forecast on Thursday, betting on surging demand for its blockbuster weight-loss drug,…

Eli Lilly raises full-year profit forecast on weight-loss drug strength

Eli Lilly raised its full-year profit forecast on Thursday, betting on surging demand for its blockbuster weight-loss drug, Zepbound, as…

Eli Lilly bricht ein, Novo Nordisk mit Mega-Rebound – das ist der Grund

Paukenschlag im Adipositas-Markt: Das US-amerikanische Pharma-Unternehmen Eli Lilly hat neben den erwarteten Zahlen zum zweiten Quartal frische Studiendaten zur Abnehm-Pille…

Eli Lilly falls after late-stage trial data for oral weight loss therapy

…

Eli Lilly shares tumble on disappointing weight loss drug trial data

Eli Lilly and Co (NYSE:LLY) shares fell more than 10% at the market open as disappointing late-stage trial data for…

Stock Market Today: Dow, S&P 500, Nasdaq Set to Open Up; Trump Tariffs Kick In; Apple, Eli Lilly, Nvidia, AMD, More Movers

Dow, S&P 500, and Nasdaq futures are rising in premarket trading as the stock market digests President Donald Trumps reciprocal…

These 2 stocks are still on our shopping list, and what Eli Lilly needs to deliver on earnings

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Amgen Stock Sinks As Market Eyes MariTides Next Move

Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that surpassed analyst expectations after…

Eli Lilly earnings are coming Thursday. Heres what top analysts expect

Wall Street is optimistic heading into Eli Lillys second-quarter earnings report.…

Wegovy maker Novo Nordisk warns on continued copycat-drug challenge as new CEO readied

Novo Nordisk cautioned on Wednesday that it expects continued competition this year from copycat versions of its Wegovy obesity drug,…

Hims & Hers Health Stock Plunges Over 13% In Tuesday Pre-Market: Whats Going On? - Hims & Hers Health (NYSE:HIMS), Eli Lilly (NYSE:LLY)

Hims & Hers Health Inc. (NYSE: HIMS) plunged 13.1% in Tuesday pre-market after the digital health company reported second-quarter revenue…

Here are the 6 big things were watching in the market in the week ahead

Disney and Eli Lilly are among the six Club stocks reporting in the coming days.…

Eli Lilly stock rises, Novo Nordisk shares jump on potential Medicare coverage By Investing.com

Eli Lilly stock rises, Novo Nordisk shares jump on potential Medicare coverage…

Eli Lilly: The Worst May Be Already Over (Earnings Preview)

…

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo Nordisk.…

Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers first choice for patients…

Eli Lilly (LLY) Declines More Than Market: Some Information for Investors

Eli Lilly (LLY) reached $762.95 at the closing of the latest trading day, reflecting a -5.59% change compared to its…

Trumps pharmaceutical tariffs could affect some drugmakers more than others

AbbVie, Bristol Myers Squibb and Eli Lilly appear "relatively well-positioned," while Novartis and Roche look more at risk, TD Cowen…

Lilly set for strong quarter after Novo profit warning

Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival…

Novo Nordisk Stock Implodes: Is Weight-Loss Bubble Bursting? - Hims & Hers Health (NYSE:HIMS), Eli Lilly (NYSE:LLY)

Novo Nordisk stock collapsed 26% in its worst trading day ever after slashing guidance on Wegovy sales and naming a…

EMA empfiehlt Zulassung von weiterem Alzheimer-Medikament

AMSTERDAM/BERLIN (dpa-AFX) - Die europäische Arzneimittelbehörde EMA hat den Weg für ein weiteres Medikament gegen Alzheimer…

How Will Eli Lillys Oncology Drugs Perform in Q2 Earnings?

LLYs oncology sales are expected to have climbed in Q2, led by Verzenio growth, despite pressure from older cancer drugs.…

Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade

Eli Lilly (LLY) closed at $762.18 in the latest trading session, marking a -1.23% move from the prior day.…

Should You Invest in This Under-the-Radar Weight Loss Stock?

Key PointsRhythm Pharmaceuticals lone approved product currently generates minimal sales.However, recent clinical progress could help change that in the coming…

Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.

Key PointsPresident Trumps tariffs could erode healthcare companies profits, but some may perform well regardless.Eli Lilly and Novartis have taken…

Is Nvidia Stock Too Expensive to Buy Now?

Key PointsData center growth is slated to continue for some time.Nvidias GPUs are unrivaled in the AI space. Many stocks…

Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?

LLYs explosive growth from Mounjaro and Zepbound outpaces MRKs Keytruda-led gains, despite valuation concerns.…

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcickis nonprofit…

Eli Lilly (LLY) Dips More Than Broader Market: What You Should Know

In the most recent trading session, Eli Lilly (LLY) closed at $771.75, indicating a -3.45% shift from the previous trading…

Top Research Reports for Eli Lilly, Netflix & GE Aerospace

LLY, NFLX, and GE lead todays top stock picks, with strong growth drivers but face headwinds from pricing, rivals, and…

3 Dividend Growth Stocks to Buy and Hold

Key PointsAbbott Laboratories is a dividend growth machine thats known for consistency.AbbVies dividend has more than quadrupled since 2013.Eli Lilly…

Can Mounjaro and Zepbound Drive Another Strong Quarter for Eli Lilly?

LLY rides high on surging demand for Mounjaro and Zepbound, now nearly half its revenues ahead of Q2 earnings.…

Eli Lilly Comes Out As ADA Winner

…

3 Reasons I Bought Novo Nordisk Stock Instead of Eli Lilly

Key PointsNovo Nordisks beaten-down valuation became too attractive to pass up, so I bought the stock earlier this year.Eli Lillys…